Table 4.
n | Female % | White % | Black % | Asian % | Hispanic % |
---|---|---|---|---|---|
Total 73,164,754 |
SDC Figure I |
SDC Figure II |
SDC Figure III |
SDC Figure IV |
SDC Figure V |
CC3 36489450 |
AN
90.31 |
OCD
85.41 |
SZ
32.91 |
TIN
2.99 |
AU
12.14 |
CC2 16026706 |
MS
74.01 |
ET
85.36 |
OB
19.06 |
AU
2.86 |
OB
12.11 |
CC1 12570742 |
MDD
69.15 |
AN
84.71 |
E
16.78 |
SP
2.52 |
CC2 10.22 |
SP 3147987 |
AD
63.39 |
TS
83.22 |
CC1 16.39 |
PD 2.49 |
CP 10.00 |
OB 2152410 |
DYS
63.33 |
PD
82.53 |
CC2 16.08 |
CP 2.37 |
CC3 9.51 |
CHP 581333 |
OB
62.19 |
MDD
78.20 |
CC3 15.00 |
CC2 2.31 |
TBI 8.98 |
TBI 431304 |
CC2 61.78 |
DYS
77.98 |
CP 14.95 |
CHP 2.18 |
E 8.30 |
E 350990 |
BP 60.98 |
CA
77.88 |
AU 14.84 |
SZ 2.04 |
DD 8.16 |
MDD 233742 |
CC1 60.87 |
MS
77.70 |
SP
14.54 |
DYS 1.96 |
MDD 7.55 |
BP 191640 |
CC3 59.83 |
CHP
75.97 |
BP
13.15 |
AD 1.94 |
CC1 7.39 |
TIN 186763 |
SP
59.51 |
AD
75.85 |
TBI
12.49 |
CC3 1.81 |
TIN
7.03 |
DD 125132 |
OCD
57.83 |
TIN
75.81 |
CHP
12.46 |
MDD 1.65 |
CHP
6.99 |
AU 115121 |
CP
56.83 |
DD
75.52 |
AD
11.88 |
E 1.63 |
SP
6.94 |
AD 104324 |
ET
50.82 |
BP
74.39 |
DD
11.52 |
AN 1.54 |
DYS
5.92 |
PD 87532 |
TIN
50.12 |
CC1 74.10 |
MS
10.62 |
TBI 1.52 |
AN
5.48 |
SZ 87209 |
E
49.90 |
CC3 73.79 |
MDD
9.99 |
CA 1.46 |
CA
5.25 |
MS 85510 |
CA
48.57 |
CC2 72.30 |
DYS
9.63 |
CC1 1.45 |
TS
4.98 |
ET 41523 |
DD
47.20 |
SP
71.91 |
CA
8.32 |
OB
1.39 |
SZ
4.84 |
CP 38009 |
CP
45.38 |
TBI
71.71 |
TIN
7.65 |
BP
1.24 |
BP
4.30 |
CA 37195 |
TBI
37.56 |
E
68.08 |
TS
7.10 |
ET
1.23 |
OCD
3.93 |
OCD 32778 |
PD
36.22 |
AU
67.76 |
OCD
5.91 |
OCD
1.14 |
MS
3.60 |
DYS 24732 |
SZ
36.07 |
OB
67.73 |
PD
4.85 |
TS
1.03 |
PD
2.80 |
TS 12352 |
TS
27.96 |
CP
66.76 |
AN
4.82 |
MS
0.65 |
ET
2.71 |
AN 10270 |
AU
20.73 |
SZ
50.65 |
ET
4.78 |
DD
0.51 |
AD
2.70 |
Columns are sorted by descending percentage. AD, Alzheimer's disease; AN, anorexia; AU, autism; BP, bipolar disorder; CP, cerebral palsy; CHP, chronic pain; CC1–3, control cohorts; CA, Huntington's disease CNS atrophy; DD, drug dependence; DYS, dystonia; E, epilepsy; ET, essential tremor; MDD, major depressive disorder; OB, obesity; OCD, obsessive-compulsive disorder; PD, Parkinson's disease; TBI, traumatic brain injury; TIN, tinnitus; MS, multiple sclerosis; SZ, schizophrenia/schizoaffective disorder; SP, chronic spinal pain; TS, Tourette's syndrome; black outline = cohorts statistically indistinct from control groups, bold = cohorts with a higher frequency than controls, italics = cohorts with lower frequency than controls, grey outline = cohorts with equal numbers of men and women.